{"id":"W2995634960","doi":"10.1016/j.ygyno.2019.10.001","title":"Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy – The GCIG symptom benefit study (SBS)","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Ipsen; Pfizer UK; Ipsen Fund; Sanofi; AstraZeneca; Janssen Biotech; Astellas Pharma; Roche; Astellas Pharma US; Pfizer","keywords":"Medicine; Chemotherapy; Oncology; Ovarian cancer; Internal medicine; Progression-free survival; Cancer; Gynecology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004138989,0.0002102821,0.0002488203,0.0003006255,0.0001849369,0.0004093828,0.0002510161,0.0004559689,0.001155436],"category_scores_gemma":[0.001637963,0.0001546153,0.0005740336,0.0004464592,0.0001679899,0.000274242,0.0003428129,0.0005755419,0.0001142369],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002246889,"about_ca_system_score_gemma":0.0003267253,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003008393,"about_ca_topic_score_gemma":0.00618878,"domain_scores_codex":[0.9998535,0.00004334432,0.00001625474,0.00002924832,0.0000216049,0.00003613329],"domain_scores_gemma":[0.9993222,0.0001692967,0.0002565973,0.00004595108,0.00003884365,0.0001671586],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001034543,0.00005857303,0.9957902,0.00001228825,0.00009251939,0.00003604793,0.00002069332,0.00008220358,0.0001881948,0.00001346111,0.0001844764,0.002486822],"study_design_scores_gemma":[0.00005510881,0.0002893165,0.9988887,0.000005036202,0.00009010497,0.0000870716,0.0000476691,0.0001818564,0.00003750271,0.00002441847,0.0002908902,0.000002397395],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985508,0.0004726915,0.00002618172,0.00009588362,0.00001404959,0.000008580927,0.0003847335,0.000002644905,0.0004443741],"genre_scores_gemma":[0.998887,0.0001362164,0.00003811136,0.00004534551,0.00002233929,0.000006891215,0.000660505,0.000001382186,0.0002021403],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003008393,"threshold_uncertainty_score":0.005981743,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01924803945143022,"score_gpt":0.3012838327553,"score_spread":0.2820357933038698,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}